Duloxetine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00476 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 47 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | benign paroxysmal torticollis of infancy | KG + DL |
| 2 | agoraphobia | KG + DL |
| 3 | obsessive-compulsive disorder | KG + DL |
| 4 | histrionic personality disorder (disease) | KG + DL |
| 5 | schizotypal personality disorder | KG + DL |
| 6 | paranoid personality disorder | KG + DL |
| 7 | schizoid personality disorder | KG + DL |
| 8 | Ohdo syndrome and variants | KG + DL |
| 9 | ligneous conjunctivitis | KG + DL |
| 10 | blepharophimosis - intellectual disability syndrome, Ohdo type | KG + DL |
| 11 | dysthymic disorder | KG + DL |
| 12 | melancholia | KG + DL |
| 13 | neurotic depression | KG + DL |
| 14 | phobic disorder | KG + DL |
| 15 | childhood apraxia of speech | KG + DL |
| 16 | Keppen-Lubinsky syndrome | KG + DL |
| 17 | surfactant metabolism dysfunction, pulmonary | KG + DL |
| 18 | post-traumatic stress disorder | KG + DL |
| 19 | neurotic disorder | KG + DL |
| 20 | chromosome 15q26-qter deletion syndrome | KG + DL |
| 21 | dependent personality disorder | KG + DL |
| 22 | congenital isolated adrenocorticotropic hormone deficiency (disease) | KG + DL |
| 23 | autosomal dominant slowed nerve conduction velocity | KG + DL |
| 24 | narcissistic personality disorder | KG + DL |
| 25 | migraine with brainstem aura | KG + DL |
| 26 | migraine disorder | KG + DL |
| 27 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
| 28 | manic bipolar affective disorder | KG + DL |
| 29 | avoidant personality disorder | KG + DL |
| 30 | tendinitis | KG + DL |
| 31 | myositis fibrosa | KG + DL |
| 32 | idiopathic granulomatous myositis | KG + DL |
| 33 | Asperger syndrome | KG + DL |
| 34 | osteoarthritis susceptibility | KG + DL |
| 35 | atrophoderma vermiculata | KG + DL |
| 36 | coronary aneurysm | KG + DL |
| 37 | mixed anxiety and depressive disorder | KG + DL |
| 38 | osteoarthritis | KG + DL |
| 39 | ulerythema ophryogenesis | KG + DL |
| 40 | inclusion body myositis | KG + DL |
| 41 | familial hypertryptophanemia | KG + DL |
| 42 | schizophrenia | KG + DL |
| 43 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 44 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 45 | brachyolmia | KG + DL |
| 46 | myosclerosis | KG + DL |
| 47 | diffuse alopecia areata | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.